Opportunities and Challenges Ahead for Nuclear Medicine Toward Achieving Trustworthy AI
| Category | Domain | Subdomain |
|---|---|---|
| Opportunities | Diagnostic imaging | Emerging nuclear imaging approaches |
| RPTs | AI-driven theranostic drug discovery and labeling | |
| Precision dosimetry | ||
| Predictive dosimetry and digital twins | ||
| Clinical workflow: increasing throughput while maintaining excellence | ||
| Challenges | Development of AI applications/medical devices | Data |
| Optimal network architecture | ||
| Measurement and communication of uncertainty | ||
| Clinically impactful use cases | ||
| Team science | ||
| Evaluation (verification of performance) | Performance profiling through task-based evaluations | |
| Guidelines for validation | ||
| Multicenter clinical trial network | ||
| Ethical, regulatory, and legal ambiguities | Ethical aspects | |
| Regulatory and legal aspects | ||
| Implementation of clinical AI solutions and postimplementation monitoring | AI platform | |
| Barriers of dissemination and implementation of AI technology in medicine | ||
| Postdeployment: change management and performance | ||
| Trust and trustworthiness |